PIB’S Bulletin on COVID-19

0
29
PIB’S BULLETIN ON COVID-19
PIB’S BULLETIN ON COVID-19
  • 195.19 cr vaccine doses have been administered so far under Nationwide Vaccination Drive

4

  • India’s Active caseload currently stands at 47,995

 

  • Active cases stand at 0.11%

 

  • Recovery Rate currently at 98.68%
  • 4,592 recoveries in the last 24 hours increases Total Recoveries to
  • 4,26,57,335

 

  • 8,084 new cases recorded in the last 24 hours

 

  • Daily positivity rate (3.24%)

 

  • Weekly Positivity Rate (2.21%)

 

  • 85.51 cr Total Tests conducted so far; 2,49,418 tests conducted in the last 24 hours

 #Unite2FightCorona                                                                                 #IndiaFightsCorona

 

Press Information Bureau

Ministry of Information & Broadcasting

Government of India

*****  

Image

 

Image

 

India’s Cumulative COVID-19 Vaccination Coverage exceeds 195.19 Cr

Over 3.51 Cr 1st dose vaccines administered for age group 12-14 years

India’s Active caseload currently stands at 47,995

8,084 new cases reported in the last 24 hours

Recovery Rate currently stands at 98.68%

Weekly Positivity Rate is presently at 2.21%

 

India’s COVID-19 vaccination coverage has exceeded 195.19 Cr (1,95,19,81,150) as per provisional reports till 7 am today. This has been achieved through 2,50,56,366 sessions.

COVID-19 vaccination for the age group 12-14 years was started on 16 March, 2022. So far, more than 3.51 Cr (3,51,48,286) adolescents have been administered with the first dose of COVID-19 vaccine. Similarly, the COVID-19 precaution dose administration for age group 18-59 years also started from 10th April, 2022 onwards.

The break-up of the cumulative figure as per the provisional report till 7 am today include:

 

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 1,04,07,764
2nd Dose 1,00,50,209
Precaution Dose 54,11,036
FLWs 1st Dose 1,84,20,731
2nd Dose 1,76,01,591
Precaution Dose 92,14,027
Age Group 12-14 years 1st Dose 3,51,48,286
2nd Dose 1,94,72,762
Age Group 15-18 years 1st Dose 5,98,65,545
2nd Dose 4,70,00,805
Age Group 18-44 years 1st Dose 55,76,46,418
2nd Dose 49,50,53,984
Precaution Dose 15,39,266
Age Group 45-59 years 1st Dose 20,33,44,863
2nd Dose 19,20,24,445
Precaution Dose 18,25,095
Over 60 years 1st Dose 12,71,67,853
2nd Dose 11,98,40,643
Precaution Dose 2,09,45,827
Precaution Dose 3,89,35,251
Total 1,95,19,81,150

 

India’s Active Caseload currently stands at 47,995. Active cases now constitute 0.11% of the country’s total Positive Cases.

https://static.pib.gov.in/WriteReadData/userfiles/image/image002EKZY.jpg

Consequently, India’s recovery rate stands at 98.68%. 4,592 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 4,26,57,335.

https://static.pib.gov.in/WriteReadData/userfiles/image/image003L3GF.jpg

 

8,084 new cases were reported in the last 24 hours.

https://static.pib.gov.in/WriteReadData/userfiles/image/image004APBA.jpg

The last 24 hours saw a total of 2,49,418 COVID-19 tests being conducted. India has so far conducted over 85.51 Cr (85,51,08,879) cumulative tests.

Weekly Positivity Rate in the country currently stands at 2.21% and the Daily Positivity rate is reported to be 3.24%.

 

https://static.pib.gov.in/WriteReadData/userfiles/image/image005F8Q7.jpg

 

https://pib.gov.in/PressReleasePage.aspx?PRID=1833388

 

Update on COVID-19 Vaccine Availability in States/UTs

More than 193.53 Crore vaccine doses provided to States/UTs

More than 13.81 Crore balance and unutilized vaccine doses still available with States/UTs

The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country. The nationwide COVID 19 vaccination started on 16th January 2021. The new phase of universalization of COVID-19 vaccination commenced from 21st June 2021. The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain.

As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.

VACCINE DOSES  

(As on 13th June 2022)

 

SUPPLIED

 

1,93,53,58,865

 

BALANCE AVAILABLE

 

 

13,81,48,965

 

More than 193.53 crore (1,93,53,58,865) vaccine doses have been provided to States/UTs so far through Govt. of India (free of cost channel) and through direct state procurement category.

More than 13.81 Cr (13,81,48,965) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.

https://pib.gov.in/PressReleasePage.aspx?PRID=1833375

 

Union Health Minister Dr Mansukh Mandaviya interacts with State Health Ministers; reviews status and progress under “HarGharDastak 2.0”

Urges States to Focus on increasing COVID Vaccination coverage of School Going Children and Precaution Dose for the Elderly

COVID not over yet; With rising COVID cases in some states, Important to be Alert and not forget COVID Appropriate Behaviour (CAB): Dr Mansukh Mandaviya

States/UTs urged to continue and Strengthen the Surveillance and focus on Genome Sequencing

“COVID is not over yet. There are reports of rising cases of COVID in some states. It is important at this time to be alert and not forget COVID Appropriate behaviour (CAB) such as wearing masks and maintaining physical distance to prevent spread of the infection”. This was stressed by Union Minister for Health and Family Welfare, Dr Mansukh Mandaviya as he chaired a meeting through Video Conference (VC) today with Health Ministers and senior officials of States and Union Territories (UTs) to review the progress of vaccination exercise HarGharDastak 2.0 campaign.

Highlighting increased case positivity in some districts and States and reduced COVID-19 testing, Dr Mandaviya stated that increased and timely testing will enable early identification of COVID cases and help to curb spread of the infection among the community. He urged States/UTs to continue and strengthen the surveillance and focus on genome sequencing for identifying new mutants/variants in the country. He stated that the five-fold strategy of Test, Track, Treat, Vaccination & Adherence to Covid Appropriate Behavior (CAB) needs to be continued and monitored by States/UTs.

For Details:- https://pib.gov.in/PressReleasePage.aspx?PRID=1833528